Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia

Abstract
AM is a 36 year old white man who was diagnosed with subfoveal CNV caused by pathological myopia (right eye = −11.50 D, left eye = −11.50 D) in his left eye in September 2002 for which he received three photodynamic therapy (PDT) treatments. He developed subfoveal CNV in his right eye in June 2003 and received one PDT treatment combined with an intravitreous injection of 4 mg of triamcinolone acetonide. In May 2004, he presented with recurrent subfoveal CNV in his right eye and refused PDT. Off-label use of bevacizumab was discussed and after informed consent, the patient decided to proceed.